Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
Unknown	0	broad.mit.edu	37	1	16974955	16974955	+	IGR	SNP	A	A	G	rs149751487	by1000genomes	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr1:16974955A>G			NA	NA				CROCCP2 (13901 upstream) : RNU1-3 (18324 downstream)						NA		NA		NA							NA						GCATGCTTTGATGTCTGGGAC	0.657		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			5.038788	KEEP			14.310828	0.090909	5	50	---	---	---	---	1	0.4968586	9	9	0	50	5	56	0	50	2	0	0	0	0	0	0	5	56	0	50	2	TP
LRRC42	115353	broad.mit.edu	37	1	54426067	54426067	+	Missense_Mutation	SNP	A	A	T			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr1:54426067A>T	ENST00000371370.3	+	5	1165	c.644A>T	c.(643-645)gAt>gTt	p.D215V	LRRC42_ENST00000319223.4_Missense_Mutation_p.D215V	NM_001256409.1	NP_001243338.1	Q9Y546	LRC42_HUMAN	leucine rich repeat containing 42	215		NA		NA						breast(2)|kidney(1)|large_intestine(1)|lung(5)	9						TGTTTATCTGATGCTGGGGTG	0.368		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						140	139	139	NA		NA	NA	1		NA											NA				54426067		2203	4300	6503	SO:0001583	missense			ENSG00000116212	HGNC:28792	NM_052940	Approved	uc001cwj.2	NA	D3DQ46|Q8N2Q8	ENST00000371370.3	37	CCDS585.1	.	.	.	.	.	.	.	.	.	.	A	26.1	4.709431	0.89018	.	.	ENSG00000116212	ENST00000371370;ENST00000319223;ENST00000444987	T;T;T	0.33216	5.32;5.32;1.42	5.85	5.85	0.93711	.	0.000000	0.85682	D	0.000000	T	0.43255	0.1239	L	0.29908	0.895	0.80722	D	1	D;D	0.59767	0.986;0.977	D;P	0.63957	0.92;0.834	T	0.33803	-0.9854	10	0.62326	D	0.03	-19.0308	16.5479	0.84454	1.0:0.0:0.0:0.0	.	215;215	E7EP35;Q9Y546	.;LRC42_HUMAN	V	215	ENSP00000360421:D215V;ENSP00000318185:D215V;ENSP00000389368:D215V	ENSP00000318185:D215V	D	+	2	0	LRRC42	54198655	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	8.090000	0.89526	2.371000	0.80710	0.533000	0.62120	GAT	LRRC42-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000023250.1	36.239946	KEEP		+	57.053853	0.135802	22	140	---	---	---	---	1	1	51	150	0	162	27	168	0	162	2	0	0	0	0	0	0	27	168	0	162	2	TP
CD48	962	broad.mit.edu	37	1	160651146	160651146	+	Silent	SNP	A	A	G			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr1:160651146A>G	ENST00000368046.3	-	3	585	c.498T>C	c.(496-498)taT>taC	p.Y166Y	RP11-404F10.2_ENST00000443928.2_RNA|RP11-404F10.2_ENST00000598917.1_RNA|RP11-404F10.2_ENST00000588034.1_RNA	NM_001778.3	NP_001769.2	P09326	CD48_HUMAN	CD48 molecule	166	Ig-like C2-type 2.	NA		NA	blood coagulation|defense response|leukocyte migration	integral to plasma membrane|membrane raft	protein binding			breast(2)|endometrium(1)|large_intestine(2)|lung(2)|ovary(1)|prostate(1)|stomach(1)	10	all_cancers(52;2.18e-17)|all_hematologic(112;0.093)		BRCA - Breast invasive adenocarcinoma(70;0.0175)			TTTTGTCCCCATACCAGGTGT	0.448		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						171	158	162	NA		NA	NA	1		NA											NA				160651146		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000117091	HGNC:1683	NM_001778	Approved	uc001fwo.2	NA	Q5U055	ENST00000368046.3	37	CCDS1208.1																																																																																			CD48-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000060471.1	-53.899594	KEEP		-	7.727974	0.017094	4	230	---	---	---	---	1	0.6076724	2	79	0	192	6	254	0	192	2	0	0	0	0	0	0	6	254	0	192	2	TP
MBOAT2	129642	broad.mit.edu	37	2	9083336	9083336	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr2:9083336T>C	ENST00000305997.3	-	3	477	c.279A>G	c.(277-279)atA>atG	p.I93M	MBOAT2_ENST00000486484.1_5'UTR	NM_138799.2	NP_620154.2	Q6ZWT7	MBOA2_HUMAN	membrane bound O-acyltransferase domain containing 2	93		NA		NA	phospholipid biosynthetic process	integral to membrane	1-acylglycerol-3-phosphate O-acyltransferase activity		MBOAT2/PRKCE(2)	endometrium(2)|kidney(1)|large_intestine(9)|lung(2)|skin(1)	15	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)					TCTCCACTCCTATGATGATCA	0.318		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ovarian(194;1699 3813 22401)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA						91	86	88	NA		NA	NA	2		NA											NA				9083336		2203	4300	6503	SO:0001583	missense			ENSG00000143797	HGNC:25193	NM_138799	Approved	uc002qzg.1	NA	A9EDR2|Q8NCE7|Q96KY4	ENST00000305997.3	37	CCDS1660.1	.	.	.	.	.	.	.	.	.	.	T	13.56	2.272224	0.40194	.	.	ENSG00000143797	ENST00000305997;ENST00000462696	T	0.10288	2.89	4.62	2.2	0.27929	.	0.539104	0.20312	N	0.094805	T	0.08088	0.0202	L	0.34521	1.04	0.26431	N	0.97594	B;P	0.38300	0.396;0.626	B;B	0.39068	0.289;0.289	T	0.23013	-1.0200	10	0.34782	T	0.22	-10.2583	6.1299	0.20199	0.1438:0.0799:0.0:0.7763	.	93;93	B7Z3I3;Q6ZWT7	.;MBOA2_HUMAN	M	93;70	ENSP00000302177:I93M	ENSP00000302177:I93M	I	-	3	3	MBOAT2	9000787	0.990000	0.36364	0.936000	0.37596	0.952000	0.60782	0.717000	0.25851	0.283000	0.22279	0.459000	0.35465	ATA	MBOAT2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000206735.1	-19.072972	KEEP		-	7.479452	0.027778	3	105	---	---	---	---	1	0.8532286	8	112	0	103	4	135	0	103	2	0	0	0	0	0	0	4	135	0	103	2	TP
CHST10	9486	broad.mit.edu	37	2	101010080	101010080	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr2:101010080C>A	ENST00000264249.3	-	7	1083	c.698G>T	c.(697-699)cGg>cTg	p.R233L	CHST10_ENST00000542617.1_Missense_Mutation_p.R281L|CHST10_ENST00000409701.1_Missense_Mutation_p.R233L	NM_004854.4	NP_004845.1	O43529	CHSTA_HUMAN	carbohydrate sulfotransferase 10	233		NA		NA	carbohydrate biosynthetic process|cell adhesion	Golgi membrane|integral to membrane|membrane fraction		p.R233L(1)		breast(1)|endometrium(1)|large_intestine(9)|lung(4)|ovary(1)	16						CTGGATCCCCCGGGTCTCTGT	0.507		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA						202	194	197	NA		NA	NA	2		NA											NA				101010080		2203	4300	6503	SO:0001583	missense			ENSG00000115526	HGNC:19650	NM_004854	Approved	uc002tam.3	NA		ENST00000264249.3	37	CCDS2047.1	.	.	.	.	.	.	.	.	.	.	C	14.48	2.548721	0.45383	.	.	ENSG00000115526	ENST00000264249;ENST00000542617;ENST00000409701	T;T;T	0.73258	-0.73;-0.73;-0.73	6.06	5.17	0.71159	.	0.254783	0.45867	D	0.000328	T	0.52661	0.1748	N	0.16790	0.44	0.31971	N	0.607181	B	0.27117	0.168	B	0.28385	0.089	T	0.58142	-0.7688	10	0.33141	T	0.24	-24.7066	8.7206	0.34439	0.0:0.7491:0.1517:0.0992	.	233	O43529	CHSTA_HUMAN	L	233;281;233	ENSP00000264249:R233L;ENSP00000438869:R281L;ENSP00000387309:R233L	ENSP00000264249:R233L	R	-	2	0	CHST10	100376512	0.983000	0.35010	1.000000	0.80357	0.919000	0.55068	0.647000	0.24812	1.557000	0.49525	0.655000	0.94253	CGG	CHST10-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253162.1	-54.778143	KEEP		-	11.08135	0.023077	6	254	---	---	---	---	1	0.7810739	2	67	0	273	8	289	0	273	2	0	0	0	0	0	0	8	289	0	273	2	TP
ATP13A4	84239	broad.mit.edu	37	3	193120598	193120598	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr3:193120598T>C	ENST00000342695.4	-	30	3756	c.3434A>G	c.(3433-3435)tAt>tGt	p.Y1145C	ATP13A4_ENST00000482964.1_5'UTR|ATP13A4_ENST00000400270.2_Missense_Mutation_p.Y161C|ATP13A4_ENST00000392443.3_Missense_Mutation_p.Y1126C	NM_032279.2	NP_115655.2	Q4VNC1	AT134_HUMAN	ATPase type 13A4	1145		NA		NA	ATP biosynthetic process|cation transport	integral to membrane	ATP binding|ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism|metal ion binding			breast(2)|central_nervous_system(1)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(9)|lung(27)|ovary(2)|prostate(3)|skin(11)|upper_aerodigestive_tract(2)	71	all_cancers(143;1.76e-08)|Ovarian(172;0.0386)		OV - Ovarian serous cystadenocarcinoma(49;2.72e-18)|LUSC - Lung squamous cell carcinoma(58;3.55e-06)|Lung(62;4.19e-06)	GBM - Glioblastoma multiforme(46;0.000109)		TTTTGACTGATAGCCGAAACA	0.443		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						82	80	80	NA		NA	NA	3		NA											NA				193120598		2203	4300	6503	SO:0001583	missense			ENSG00000127249	HGNC:25422	NM_032279	Approved	uc003ftd.3	NA	B7WPC7|Q6UY23|Q8N1Q9|Q9H043	ENST00000342695.4	37	CCDS3304.2	.	.	.	.	.	.	.	.	.	.	T	10.34	1.322831	0.23994	.	.	ENSG00000127249	ENST00000400270;ENST00000392443;ENST00000342695	T;T;T	0.59502	0.26;0.26;0.26	5.3	5.3	0.74995	.	0.000000	0.64402	D	0.000013	T	0.47173	0.1431	L	0.29908	0.895	0.80722	D	1	B	0.18166	0.026	B	0.23419	0.046	T	0.40496	-0.9560	10	0.39692	T	0.17	-22.3835	13.5323	0.61629	0.0:0.0:0.0:1.0	.	1145	Q4VNC1	AT134_HUMAN	C	161;1126;1145	ENSP00000383129:Y161C;ENSP00000376238:Y1126C;ENSP00000339182:Y1145C	ENSP00000339182:Y1145C	Y	-	2	0	ATP13A4	194603292	0.983000	0.35010	0.990000	0.47175	0.211000	0.24417	1.675000	0.37555	2.136000	0.66102	0.486000	0.48141	TAT	ATP13A4-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000157244.4	-9.132182	KEEP		-	7.680674	0.040541	3	71	---	---	---	---	1	0.9975402	52	413	0	76	3	82	0	76	2	0	0	0	0	0	0	3	82	0	76	2	TP
CCNB1	891	broad.mit.edu	37	5	68470156	68470156	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr5:68470156C>A	ENST00000256442.5	+	5	878	c.625C>A	c.(625-627)Cta>Ata	p.L209I	snoU13_ENST00000459230.1_RNA	NM_031966.3	NP_114172.1	P14635	CCNB1_HUMAN	cyclin B1	209		NA		NA	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|cell division|G1/S transition of mitotic cell cycle|G2/M transition of mitotic cell cycle|mitotic cell cycle spindle checkpoint|mitotic metaphase plate congression|mitotic prometaphase|mitotic spindle stabilization|positive regulation of attachment of spindle microtubules to kinetochore|positive regulation of mitotic cell cycle|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|regulation of cyclin-dependent protein kinase activity	condensed nuclear chromosome outer kinetochore|cytosol|microtubule organizing center|nucleoplasm|spindle pole				large_intestine(2)|lung(5)|skin(1)	8		Lung NSC(167;5.51e-05)|Prostate(74;0.00634)|Ovarian(174;0.0448)|Breast(144;0.198)		OV - Ovarian serous cystadenocarcinoma(47;1.24e-56)|Epithelial(20;1.12e-52)|all cancers(19;2.63e-48)|Lung(70;0.0177)		AATTGACTGGCTAGTACAGGT	0.433		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						186	176	179	NA		NA	NA	5		NA											NA				68470156		2203	4300	6503	SO:0001583	missense			ENSG00000134057	HGNC:1579	NM_031966	Approved	uc003jvm.3	NA		ENST00000256442.5	37	CCDS3997.1	.	.	.	.	.	.	.	.	.	.	C	20.4	3.990385	0.74589	.	.	ENSG00000134057	ENST00000256442;ENST00000506572;ENST00000505500;ENST00000507798	T;T;T;T	0.23754	1.89;1.89;1.89;1.89	6.16	5.13	0.70059	Cyclin, N-terminal (2);Cyclin-like (3);	0.000000	0.85682	D	0.000000	T	0.49064	0.1535	M	0.68728	2.09	0.80722	D	1	D;D;D	0.89917	1.0;0.997;0.975	D;D;D	0.87578	0.998;0.951;0.927	T	0.33879	-0.9851	10	0.48119	T	0.1	.	15.3639	0.74503	0.0:0.921:0.0:0.079	.	209;209;209	E9PC90;Q5TZP9;P14635	.;.;CCNB1_HUMAN	I	209;209;209;25	ENSP00000256442:L209I;ENSP00000423387:L209I;ENSP00000424588:L209I;ENSP00000426230:L25I	ENSP00000256442:L209I	L	+	1	2	CCNB1	68505912	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	3.990000	0.56965	2.937000	0.99478	0.650000	0.86243	CTA	CCNB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000215084.1	-48.001405	KEEP		+	6.620756	0.019048	4	206	---	---	---	---	1	0.5531045	2	87	0	207	4	216	0	207	2	0	0	0	0	0	0	4	216	0	207	2	TP
PCDHA10	0	broad.mit.edu	37	5	140237249	140237249	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr5:140237249G>C	ENST00000307360.5	+	1	1616	c.1616G>C	c.(1615-1617)gGg>gCg	p.G539A	PCDHA4_ENST00000512229.2_Intron|PCDHA10_ENST00000506939.2_Intron|PCDHA1_ENST00000504120.2_Intron|PCDHA1_ENST00000394633.3_Intron|PCDHA9_ENST00000532602.1_Intron|PCDHA8_ENST00000531613.1_Intron|PCDHA4_ENST00000530339.1_Intron|PCDHA5_ENST00000529859.1_Intron|PCDHA5_ENST00000529619.1_Intron|PCDHA6_ENST00000529310.1_Intron|PCDHA6_ENST00000527624.1_Intron|PCDHA2_ENST00000526136.1_Intron|PCDHA7_ENST00000525929.1_Intron|PCDHA3_ENST00000522353.2_Intron	NM_018901.2|NM_031859.1	NP_061724.1|NP_114065.1				NA		NA		NA				p.G539A(2)		NS(1)|breast(11)|cervix(1)|endometrium(11)|kidney(5)|large_intestine(13)|liver(2)|lung(20)|ovary(3)|pancreas(1)|prostate(3)|skin(6)|upper_aerodigestive_tract(2)	79			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)			GCGCGCGATGGGGGCGTGCCG	0.687		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				2	Substitution - Missense(2)	urinary_tract(1)|kidney(1)	NA	NA	NA	NA	NA						53	57	56	NA		NA	NA	5		NA											NA				140237249		2196	4266	6462	SO:0001583	missense								NA		ENST00000307360.5	37	CCDS54921.1	.	.	.	.	.	.	.	.	.	.	C	0	-2.655795	0.00108	.	.	ENSG00000250120	ENST00000307360	T	0.50277	0.75	3.63	2.76	0.32466	Cadherin (4);Cadherin-like (1);	.	.	.	.	T	0.32102	0.0818	L	0.31752	0.955	0.21841	N	0.999515	B;B	0.06786	0.001;0.001	B;B	0.14578	0.011;0.009	T	0.17653	-1.0362	9	0.02654	T	1	.	13.5065	0.61486	0.0:0.7018:0.2982:0.0	.	539;539	Q9Y5I2-3;Q9Y5I2	.;PCDAA_HUMAN	A	539	ENSP00000304234:G539A	ENSP00000304234:G539A	G	+	2	0	PCDHA10	140217433	0.000000	0.05858	0.992000	0.48379	0.064000	0.16182	0.168000	0.16622	0.861000	0.35504	-0.220000	0.12472	GGG	PCDHA10-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000372895.2	-36.691839	KEEP		+	7.018613	0.02809	5	173	---	---	---	---	1	0.2145693	4	25	1	180	5	196	1	180	2	0	0	0	0	0	0	5	196	1	180	2	TP
BTN2A1	11120	broad.mit.edu	37	6	26465519	26465519	+	Missense_Mutation	SNP	A	A	T			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr6:26465519A>T	ENST00000429381.1	+	5	1031	c.819A>T	c.(817-819)caA>caT	p.Q273H	BTN2A1_ENST00000312541.5_Missense_Mutation_p.Q273H|BTN2A1_ENST00000469185.1_Missense_Mutation_p.Q273H|BTN2A1_ENST00000541522.1_Missense_Mutation_p.Q212H			Q7KYR7	BT2A1_HUMAN	butyrophilin, subfamily 2, member A1	273		NA		NA	lipid metabolic process	integral to plasma membrane				breast(3)|central_nervous_system(1)|cervix(1)|endometrium(2)|large_intestine(2)|lung(9)|ovary(2)|prostate(1)|skin(3)|urinary_tract(3)	27						ACAAACTCCAAAAGGAAAAAA	0.433		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						136	138	137	NA		NA	NA	6		NA											NA				26465519		2203	4300	6503	SO:0001583	missense			ENSG00000112763	HGNC:1136	NM_007049	Approved	uc003nib.2	NA	O00475|P78408|Q7KYQ7|Q7Z386|Q9NU62	ENST00000429381.1	37	CCDS47390.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	5.771|5.771	0.326684|0.326684	0.10900|0.10900	.|.	.|.	ENSG00000112763|ENSG00000112763	ENST00000480218|ENST00000312541;ENST00000541522;ENST00000429381;ENST00000265424;ENST00000469185	.|T;T;T;T	.|0.76839	.|-0.49;1.09;-1.05;-1.03	3.78|3.78	-5.26|-5.26	0.02772|0.02772	.|.	.|0.454507	.|0.18608	.|N	.|0.136232	T|T	0.32346|0.32346	0.0826|0.0826	L|L	0.41356|0.41356	1.27|1.27	0.09310|0.09310	N|N	1|1	.|B;B;B	.|0.06786	.|0.0;0.0;0.001	.|B;B;B	.|0.06405	.|0.001;0.002;0.001	T|T	0.37753|0.37753	-0.9692|-0.9692	5|10	.|0.15066	.|T	.|0.55	.|.	1.9264|1.9264	0.03318|0.03318	0.138:0.272:0.1269:0.4631|0.138:0.272:0.1269:0.4631	.|.	.|212;273;273	.|B4DLP9;Q96AV7;Q7KYR7	.|.;.;BT2A1_HUMAN	I|H	22|273;212;273;259;273	.|ENSP00000312158:Q273H;ENSP00000443909:Q212H;ENSP00000416945:Q273H;ENSP00000419043:Q273H	.|ENSP00000265424:Q259H	K|Q	+|+	2|3	0|2	BTN2A1|BTN2A1	26573498|26573498	0.000000|0.000000	0.05858|0.05858	0.000000|0.000000	0.03702|0.03702	0.025000|0.025000	0.11179|0.11179	-2.644000|-2.644000	0.00862|0.00862	-1.504000|-1.504000	0.01810|0.01810	-0.714000|-0.714000	0.03626|0.03626	AAA|CAA	BTN2A1-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000354193.1	-15.220104	KEEP		+	20.172839	0.062147	11	166	---	---	---	---	1	0.824837	7	48	0	190	11	182	0	190	2	0	0	0	0	0	0	11	182	0	190	2	TP
ETV1	2115	broad.mit.edu	37	7	13971268	13971268	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr7:13971268G>C	ENST00000343495.5	-	8	1345	c.607C>G	c.(607-609)Ccc>Gcc	p.P203A	ETV1_ENST00000403527.1_Missense_Mutation_p.P181A|ETV1_ENST00000430479.1_Missense_Mutation_p.P221A|ETV1_ENST00000420159.2_Missense_Mutation_p.P163A|ETV1_ENST00000405358.4_Missense_Mutation_p.P235A|ETV1_ENST00000405192.2_Missense_Mutation_p.P221A|ETV1_ENST00000242066.5_Missense_Mutation_p.P203A|ETV1_ENST00000405218.2_Missense_Mutation_p.P221A|ETV1_ENST00000399357.3_Missense_Mutation_p.P118A|ETV1_ENST00000403685.1_Missense_Mutation_p.P203A|ETV1_ENST00000476720.2_5'UTR			P50549	ETV1_HUMAN	ets variant 1	221		NA		NA	transcription from RNA polymerase II promoter	nucleus	sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity		TMPRSS2/ETV1(34)|ACSL3_ENST00000357430/ETV1(2)|EWSR1/ETV1(7)|KLK2/ETV1(3)|SLC45A3/ETV1(3)|HNRNPA2B1/ETV1(8)	breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(9)|lung(15)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)	31						GGTGGGAAGGGGATGTTTGGC	0.552		NA	T	"""EWSR1, TMPRSS2, SLC45A3, C15orf21, HNRNPA2B1. ACSL3"""	"""Ewing sarcoma, prostate"""	NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	Dom	yes	NA	7	7p22	2115	ets variant gene 1		"""M, E"""	0			NA	NA	NA	NA	NA						146	143	144	NA		NA	NA	7		NA											NA				13971268		2024	4193	6217	SO:0001583	missense			ENSG00000006468	HGNC:3490	NM_004956	Approved	uc003ssw.4	NA	A4D118|B2R768|B7Z2I4|O75849|Q4KMQ6|Q9UQ71|Q9Y636	ENST00000343495.5	37	CCDS55086.1	.	.	.	.	.	.	.	.	.	.	G	22.9	4.347044	0.82022	.	.	ENSG00000006468	ENST00000430479;ENST00000242066;ENST00000343495;ENST00000420159;ENST00000399357;ENST00000405192;ENST00000405358;ENST00000403527;ENST00000405218;ENST00000403685;ENST00000438956;ENST00000443608	T;T;T;T;T;T;T;T;T;T;T;T	0.26067	1.76;1.76;1.76;1.76;1.76;1.76;1.76;1.76;1.76;1.76;1.76;1.76	6.13	6.13	0.99165	PEA3-type ETS-domain transcription factor, N-terminal (1);	0.051858	0.85682	D	0.000000	T	0.55273	0.1910	M	0.73598	2.24	0.80722	D	1	B;B;P;D;B;B;B;B	0.71674	0.349;0.009;0.489;0.998;0.314;0.349;0.005;0.011	B;B;B;D;B;B;B;B	0.78314	0.171;0.012;0.253;0.991;0.423;0.298;0.018;0.021	T	0.51100	-0.8748	10	0.59425	D	0.04	.	20.8401	0.99726	0.0:0.0:1.0:0.0	.	232;203;235;163;118;181;163;221	Q59GA7;P50549-2;B5MCT2;F5GXR2;B7Z9P2;E9PHB1;B7Z618;P50549	.;.;.;.;.;.;.;ETV1_HUMAN	A	221;203;203;163;118;221;235;181;221;203;163;118	ENSP00000405327:P221A;ENSP00000242066:P203A;ENSP00000340853:P203A;ENSP00000411626:P163A;ENSP00000382293:P118A;ENSP00000385381:P221A;ENSP00000384085:P235A;ENSP00000384138:P181A;ENSP00000385551:P221A;ENSP00000385686:P203A;ENSP00000393078:P163A;ENSP00000394710:P118A	ENSP00000242066:P203A	P	-	1	0	ETV1	13937793	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	9.225000	0.95219	2.932000	0.99384	0.644000	0.83932	CCC	ETV1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-0.379075	KEEP		-	11.006504	0.079365	5	58	---	---	---	---	1	0.9994511	9	142	0	58	7	63	0	58	2	0	0	0	0	0	0	7	63	0	58	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA						112	104	107	NA		NA	NA	7		NA											NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	95.977449	KEEP		-	98.211132	0.336842	32	63	---	---	---	---	1	0.9993211	10	16	0	102	37	71	0	102	2	1	1	205	358	1	695	37	71	0	102	7	TP
NBN	4683	broad.mit.edu	37	8	90958472	90958472	+	Silent	SNP	A	A	G			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr8:90958472A>G	ENST00000265433.3	-	13	2120	c.1966T>C	c.(1966-1968)Ttg>Ctg	p.L656L	NBN_ENST00000409330.1_Silent_p.L574L	NM_002485.4	NP_002476.2	O60934	NBN_HUMAN	nibrin	656		NA		NA	cell cycle arrest|DNA damage response, signal transduction by p53 class mediator|DNA duplex unwinding|double-strand break repair via homologous recombination|meiosis|mitotic cell cycle G1/S transition checkpoint|mitotic cell cycle G2/M transition DNA damage checkpoint|positive regulation of kinase activity|positive regulation of protein autophosphorylation|regulation of DNA-dependent DNA replication initiation|telomere maintenance	Mre11 complex|nuclear chromosome, telomeric region|nuclear inclusion body|nucleolus|nucleoplasm	protein N-terminus binding|transcription factor binding			autonomic_ganglia(1)|central_nervous_system(3)|endometrium(4)|kidney(3)|large_intestine(2)|lung(7)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(1)	27			BRCA - Breast invasive adenocarcinoma(11;0.0344)			AATTCAGTCAATAACAGCTTT	0.318		NA				NA		Homologous recombination					NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						121	125	123	NA		NA	NA	8		NA											NA				90958472		2203	4299	6502	SO:0001819	synonymous_variant			ENSG00000104320	HGNC:7652	NM_001024688	Approved	uc003yej.1	NA	B2R626|B2RNC5|O60672|Q32NF7|Q53FM6|Q63HR6|Q7LDM2	ENST00000265433.3	37	CCDS6249.1																																																																																			NBN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000331583.3	-27.92372	KEEP		-	9.202468	0.026667	4	146	---	---	---	---	1	0.8705529	13	148	0	147	4	171	0	147	2	0	0	0	0	0	0	4	171	0	147	2	TP
AGO2	27161	broad.mit.edu	37	8	141549494	141549494	+	Silent	SNP	G	G	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr8:141549494G>A	ENST00000220592.5	-	16	2206	c.2094C>T	c.(2092-2094)taC>taT	p.Y698Y	AGO2_ENST00000519980.1_Silent_p.Y698Y	NM_012154.3	NP_036286.2			argonaute RISC catalytic component 2	NA		NA		NA							NA						TCCCGGGCTGGTAGTCTTTTT	0.557		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						105	92	96	NA		NA	NA	8		NA											NA				141549494		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000123908	HGNC:3263		Approved		NA		ENST00000220592.5	37	CCDS6380.1																																																																																			AGO2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000377866.4	4.141912	KEEP		-	23.262348	0.094828	11	105	---	---	---	---	1	0.8068035	2	32	0	81	11	115	0	81	2	0	0	0	0	0	0	11	115	0	81	2	TP
GAPVD1	26130	broad.mit.edu	37	9	128118129	128118129	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr9:128118129C>A	ENST00000470056.1	+	22	4043	c.3883C>A	c.(3883-3885)Cgc>Agc	p.R1295S	GAPVD1_ENST00000394105.2_Missense_Mutation_p.R1349S|GAPVD1_ENST00000394104.2_Missense_Mutation_p.R1340S|GAPVD1_ENST00000312123.9_Missense_Mutation_p.R1301S|GAPVD1_ENST00000495955.1_Missense_Mutation_p.R1340S|GAPVD1_ENST00000394083.2_Missense_Mutation_p.R1274S|GAPVD1_ENST00000265956.4_Missense_Mutation_p.R1314S|GAPVD1_ENST00000297933.6_Missense_Mutation_p.R1322S			Q14C86	GAPD1_HUMAN	GTPase activating protein and VPS9 domains 1	1340		NA		NA	endocytosis|regulation of protein transport|regulation of small GTPase mediated signal transduction|signal transduction	cytosol|endosome|membrane	GTPase activating protein binding|GTPase activator activity|guanyl-nucleotide exchange factor activity			central_nervous_system(2)|endometrium(7)|kidney(4)|large_intestine(10)|lung(11)|ovary(2)|prostate(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	44						GGACATACTTCGCGACCAGTA	0.458		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						99	85	89	NA		NA	NA	9		NA											NA				128118129		2203	4300	6503	SO:0001583	missense			ENSG00000165219	HGNC:23375		Approved	uc004bpr.3	NA	A8MYK3|B0QZ62|B0QZ63|B0QZ64|Q14C76|Q2Q1W1|Q8ND92|Q8WU86|Q96CZ4|Q9NXQ1|Q9P207|Q9Y4N0	ENST00000470056.1	37		.	.	.	.	.	.	.	.	.	.	C	25.0	4.588146	0.86851	.	.	ENSG00000165219	ENST00000470056;ENST00000394105;ENST00000394104;ENST00000265956;ENST00000394083;ENST00000495955;ENST00000297933;ENST00000312123;ENST00000438537	T;T;T;T;T;T;T;T	0.29917	1.55;1.55;1.55;1.55;1.55;1.55;1.55;1.55	6.1	6.1	0.99115	Vacuolar sorting protein 9 (1);	0.000000	0.85682	D	0.000000	T	0.60932	0.2307	M	0.81802	2.56	0.80722	D	1	D;D;D;D;D;D	0.76494	0.967;0.997;0.998;0.999;0.998;0.996	P;D;D;D;D;D	0.75020	0.832;0.915;0.97;0.985;0.97;0.977	T	0.62224	-0.6899	10	0.87932	D	0	.	19.7028	0.96062	0.0:1.0:0.0:0.0	.	1340;355;1295;1301;1322;1349	Q14C86;B3KTX2;Q14C86-3;Q14C86-4;Q14C86-2;Q14C86-6	GAPD1_HUMAN;.;.;.;.;.	S	1295;1349;1340;1314;1274;1340;1322;1301;33	ENSP00000419767:R1295S;ENSP00000377665:R1349S;ENSP00000377664:R1340S;ENSP00000265956:R1314S;ENSP00000377645:R1274S;ENSP00000419063:R1340S;ENSP00000297933:R1322S;ENSP00000309582:R1301S	ENSP00000265956:R1314S	R	+	1	0	GAPVD1	127157950	0.999000	0.42202	1.000000	0.80357	0.970000	0.65996	3.619000	0.54196	2.902000	0.99343	0.650000	0.86243	CGC	GAPVD1-002	NOVEL	basic	protein_coding	NA	protein_coding	OTTHUMT00000054071.4	-8.430107	KEEP		+	6.694283	0.044118	3	65	---	---	---	---	1	0.9193337	2	89	0	94	4	76	0	94	2	0	0	0	0	0	0	4	76	0	94	2	TP
ABL1	25	broad.mit.edu	37	9	133753888	133753888	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr9:133753888G>A	ENST00000318560.5	+	8	1738	c.1357G>A	c.(1357-1359)Gag>Aag	p.E453K		NM_005157.4	NP_005148.2	P00519	ABL1_HUMAN	c-abl oncogene 1, non-receptor tyrosine kinase	453	Protein kinase.	NA		NA	actin cytoskeleton organization|axon guidance|blood coagulation|cell adhesion|DNA damage induced protein phosphorylation|DNA damage response, signal transduction resulting in induction of apoptosis|mismatch repair|muscle cell differentiation|negative regulation of protein serine/threonine kinase activity|peptidyl-tyrosine phosphorylation|positive regulation of muscle cell differentiation|positive regulation of oxidoreductase activity|regulation of transcription involved in S phase of mitotic cell cycle	cytoskeleton|cytosol|nuclear membrane|nucleolus|perinuclear region of cytoplasm	ATP binding|DNA binding|magnesium ion binding|manganese ion binding|mitogen-activated protein kinase binding|non-membrane spanning protein tyrosine kinase activity|proline-rich region binding|protein C-terminus binding|SH3 domain binding	p.E453Q(1)		breast(3)|central_nervous_system(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1149)|kidney(3)|large_intestine(7)|lung(15)|ovary(1)|skin(4)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	1195		all_hematologic(13;0.0361)|Acute lymphoblastic leukemia(5;0.0543)|Myeloproliferative disorder(178;0.204)		OV - Ovarian serous cystadenocarcinoma(145;5.4e-05)	Adenosine triphosphate(DB00171)|Dasatinib(DB01254)|Imatinib(DB00619)	TGAGCTGCTAGAGAAGGACTA	0.507		NA	"""T, Mis"""	"""BCR, ETV6, NUP214"""	"""CML, ALL, T-ALL"""	NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	Dom	yes	NA	9	9q34.1	25	v-abl Abelson murine leukemia viral oncogene homolog 1		L	1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA						171	168	169	NA		NA	NA	9		NA											NA				133753888		2203	4300	6503	SO:0001583	missense			ENSG00000097007	HGNC:76	NM_007313	Approved	uc004bzv.3	NA	A3KFJ3|Q13869|Q13870|Q16133|Q17R61|Q45F09	ENST00000318560.5	37	CCDS35166.1	.	.	.	.	.	.	.	.	.	.	G	33	5.200620	0.94997	.	.	ENSG00000097007	ENST00000444970;ENST00000372348;ENST00000318560	D;D	0.82255	-1.59;-1.59	5.01	4.11	0.48088	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.108051	0.64402	D	0.000008	D	0.84991	0.5595	L	0.33485	1.01	0.80722	D	1	P;P	0.52842	0.956;0.956	P;D	0.64776	0.881;0.929	D	0.86242	0.1644	10	0.87932	D	0	.	12.6609	0.56813	0.0804:0.0:0.9196:0.0	.	453;490	P00519;Q59FK4	ABL1_HUMAN;.	K	268;472;453	ENSP00000361423:E472K;ENSP00000323315:E453K	ENSP00000323315:E453K	E	+	1	0	ABL1	132743709	1.000000	0.71417	0.990000	0.47175	0.893000	0.52053	7.885000	0.87282	1.236000	0.43740	0.655000	0.94253	GAG	ABL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054684.1	-72.920235	KEEP		+	8.701127	0.016234	5	303	---	---	---	---	1	0.9306603	6	268	0	354	6	342	0	354	2	0	0	0	0	0	0	6	342	0	354	2	TP
ITGB1	3688	broad.mit.edu	37	10	33215004	33215004	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr10:33215004G>C	ENST00000396033.2	-	6	716	c.581C>G	c.(580-582)cCt>cGt	p.P194R	ITGB1_ENST00000423113.1_Missense_Mutation_p.P194R|ITGB1_ENST00000302278.3_Missense_Mutation_p.P194R|ITGB1_ENST00000484088.1_5'UTR|ITGB1_ENST00000374956.4_Missense_Mutation_p.P194R	NM_133376.2	NP_596867.1	P05556	ITB1_HUMAN	integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)	194	VWFA.	NA		NA	axon guidance|blood coagulation|cell-cell adhesion mediated by integrin|cell-matrix adhesion|cellular defense response|homophilic cell adhesion|integrin-mediated signaling pathway|interspecies interaction between organisms|leukocyte cell-cell adhesion|leukocyte migration|positive regulation of apoptosis|regulation of immune response	cell surface|cleavage furrow|focal adhesion|melanosome|neuromuscular junction|ruffle|sarcolemma	identical protein binding|protein heterodimerization activity|receptor activity			autonomic_ganglia(1)|breast(2)|endometrium(5)|kidney(2)|large_intestine(8)|lung(11)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	37		Ovarian(717;1.34e-05)|Breast(68;0.0634)				GCTAATGTAAGGCATCACAGT	0.403		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						116	105	108	NA		NA	NA	10		NA											NA				33215004		2203	4300	6503	SO:0001583	missense			ENSG00000150093	HGNC:6153	NM_002211	Approved	uc001iwt.4	NA	A8K6N2|D3DRX9|D3DRY3|D3DRY4|D3DRY5|P78466|P78467|Q13089|Q13090|Q13091|Q13212|Q14622|Q14647|Q29RW2|Q7Z3V1|Q8WUM6	ENST00000396033.2	37	CCDS7174.1	.	.	.	.	.	.	.	.	.	.	G	29.3	4.993930	0.93167	.	.	ENSG00000150093	ENST00000396033;ENST00000423113;ENST00000302278;ENST00000374956	D;D;D;D	0.96200	-3.94;-3.94;-3.94;-3.94	5.74	5.74	0.90152	Integrin beta subunit, N-terminal (2);von Willebrand factor, type A (1);	0.000000	0.85682	D	0.000000	D	0.98645	0.9546	H	0.96048	3.76	0.80722	D	1	D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0	D;D;D;D;D	0.97110	1.0;1.0;1.0;0.999;1.0	D	0.99267	1.0892	10	0.87932	D	0	.	19.9145	0.97053	0.0:0.0:1.0:0.0	.	194;194;194;194;194	P05556-2;P05556;P05556-5;P05556-3;P05556-4	.;ITB1_HUMAN;.;.;.	R	194	ENSP00000379350:P194R;ENSP00000388694:P194R;ENSP00000303351:P194R;ENSP00000364094:P194R	ENSP00000303351:P194R	P	-	2	0	ITGB1	33255010	1.000000	0.71417	1.000000	0.80357	0.986000	0.74619	9.869000	0.99810	2.709000	0.92574	0.655000	0.94253	CCT	ITGB1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000047496.1	-11.451553	KEEP		-	12.662052	0.052632	6	108	---	---	---	---	1	0.9999998	55	902	0	95	7	115	0	95	2	0	0	0	0	0	0	7	115	0	95	2	TP
DLAT	1737	broad.mit.edu	37	11	111933176	111933176	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr11:111933176C>T	ENST00000280346.6	+	14	2520	c.1861C>T	c.(1861-1863)Cgg>Tgg	p.R621W	DLAT_ENST00000393051.1_Missense_Mutation_p.R516W|DLAT_ENST00000537636.1_Missense_Mutation_p.R392W	NM_001931.4	NP_001922.2	P10515	ODP2_HUMAN	dihydrolipoamide S-acetyltransferase	621	Catalytic (By similarity).	NA		NA	glycolysis|regulation of acetyl-CoA biosynthetic process from pyruvate	mitochondrial pyruvate dehydrogenase complex	dihydrolipoyllysine-residue acetyltransferase activity|protein binding			breast(2)|endometrium(1)|kidney(3)|large_intestine(4)|lung(10)|ovary(1)|skin(1)	22		all_cancers(61;4.53e-11)|all_epithelial(67;2.76e-06)|Melanoma(852;9.42e-06)|all_hematologic(158;0.000885)|Acute lymphoblastic leukemia(157;0.000966)|Breast(348;0.0512)|Medulloblastoma(222;0.0523)|all_neural(223;0.0663)		Epithelial(105;4.87e-07)|BRCA - Breast invasive adenocarcinoma(274;6.83e-07)|all cancers(92;9.63e-06)|OV - Ovarian serous cystadenocarcinoma(223;0.0557)	NADH(DB00157)	TTGTGATCACCGGGTGGTGGA	0.388		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						174	179	178	NA		NA	NA	11		NA											NA				111933176		2201	4297	6498	SO:0001583	missense			ENSG00000150768	HGNC:2896	NM_001931	Approved	uc001pmo.3	NA	Q16783|Q53EP3	ENST00000280346.6	37	CCDS8354.1	.	.	.	.	.	.	.	.	.	.	C	28.0	4.884959	0.91814	.	.	ENSG00000150768	ENST00000280346;ENST00000393051;ENST00000531306;ENST00000537636	T;T;T;T	0.71461	-0.57;-0.57;-0.57;-0.57	5.98	5.07	0.68467	2-oxoacid dehydrogenase acyltransferase, catalytic domain (1);Chloramphenicol acetyltransferase-like domain (1);	0.000000	0.85682	D	0.000000	D	0.91492	0.7314	H	0.99764	4.76	0.80722	D	1	D;P;D	0.89917	1.0;0.634;1.0	D;B;D	0.87578	0.998;0.207;0.998	D	0.95193	0.8310	10	0.87932	D	0	-1.3782	15.3276	0.74179	0.0:0.933:0.0:0.067	.	621;516;621	Q86YI5;E9PEJ4;P10515	.;.;ODP2_HUMAN	W	621;516;453;392	ENSP00000280346:R621W;ENSP00000376771:R516W;ENSP00000433432:R453W;ENSP00000442427:R392W	ENSP00000280346:R621W	R	+	1	2	DLAT	111438386	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	3.535000	0.53575	1.541000	0.49316	0.591000	0.81541	CGG	DLAT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000258167.1	-49.875122	KEEP		+	6.476329	0.018519	4	212	---	---	---	---	1	0.8095964	2	169	0	216	5	278	0	216	2	0	0	0	0	0	0	5	278	0	216	2	TP
AQP5	362	broad.mit.edu	37	12	50357368	50357368	+	Missense_Mutation	SNP	C	C	A	rs146762965		THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr12:50357368C>A	ENST00000293599.6	+	2	605	c.457C>A	c.(457-459)Cgc>Agc	p.R153S	RP11-469H8.6_ENST00000552379.1_RNA|RP11-469H8.6_ENST00000550530.1_RNA|RP11-469H8.6_ENST00000550214.1_RNA	NM_001651.2	NP_001642.1	P55064	AQP5_HUMAN	aquaporin 5	153		NA		NA	carbon dioxide transport|excretion|odontogenesis|pancreatic juice secretion	apical plasma membrane|integral to plasma membrane	protein binding|water channel activity			large_intestine(1)|lung(3)	4						CACTGACTCCCGCCGCACCAG	0.627		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						96	82	87	NA		NA	NA	12		NA											NA				50357368		2203	4300	6503	SO:0001583	missense				HGNC:638	NM_001651	Approved	uc001rvo.3	NA	Q6FGW8	ENST00000293599.6	37	CCDS8793.1	.	.	.	.	.	.	.	.	.	.	C	16.97	3.268798	0.59540	.	.	ENSG00000161798	ENST00000293599	D	0.93488	-3.23	4.31	3.4	0.38934	Aquaporin-like (2);	0.000000	0.56097	D	0.000033	D	0.95658	0.8588	M	0.87097	2.86	0.34856	D	0.742107	D	0.56287	0.975	P	0.56163	0.793	D	0.98192	1.0463	10	0.87932	D	0	-0.1704	11.4999	0.50430	0.181:0.819:0.0:0.0	.	153	P55064	AQP5_HUMAN	S	153	ENSP00000293599:R153S	ENSP00000293599:R153S	R	+	1	0	AQP5	48643635	0.998000	0.40836	0.962000	0.40283	0.891000	0.51852	3.886000	0.56190	1.156000	0.42514	-0.181000	0.13052	CGC	AQP5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000405542.2	-29.63581	KEEP		+	7.507356	0.026667	4	146	---	---	---	---	1	0.6931232	8	104	0	194	4	200	0	194	2	0	0	0	0	0	0	4	200	0	194	2	TP
DAPK2	23604	broad.mit.edu	37	15	64218190	64218190	+	Silent	SNP	C	C	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr15:64218190C>A	ENST00000261891.3	-	7	767	c.762G>T	c.(760-762)acG>acT	p.T254T	DAPK2_ENST00000457488.1_Silent_p.T254T|DAPK2_ENST00000558069.1_Silent_p.T254T|RP11-111E14.1_ENST00000558050.1_RNA			Q9UIK4	DAPK2_HUMAN	death-associated protein kinase 2	254	Protein kinase.	NA		NA	apoptosis|induction of apoptosis|intracellular protein kinase cascade	cytoplasm	ATP binding|calmodulin binding|calmodulin-dependent protein kinase activity|identical protein binding			breast(1)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(2)|lung(2)|skin(1)|stomach(1)	11				LUAD - Lung adenocarcinoma(2;0.215)		CCAGCTCGCTCGTCTGGCTGA	0.498		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						142	134	137	NA		NA	NA	15		NA											NA				64218190		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000035664	HGNC:2675	NM_014326	Approved	uc002amr.3	NA	O75892|Q24JS1	ENST00000261891.3	37	CCDS10188.1																																																																																			DAPK2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-43.538392	KEEP		-	6.653046	0.020513	4	191	---	---	---	---	1	0.9999427	3	1838	0	160	4	204	0	160	2	0	0	0	0	0	0	4	204	0	160	2	TP
TM2D3	80213	broad.mit.edu	37	15	102182710	102182710	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr15:102182710C>T	ENST00000561373.1	-	4	1077	c.521G>A	c.(520-522)gGa>gAa	p.G174E	TM2D3_ENST00000333202.3_Missense_Mutation_p.G239E|TM2D3_ENST00000347970.3_Missense_Mutation_p.G213E|TM2D3_ENST00000559107.1_Intron|TM2D3_ENST00000428002.2_Intron			Q9BRN9	TM2D3_HUMAN	TM2 domain containing 3	239		NA		NA		integral to membrane				central_nervous_system(1)|endometrium(2)|lung(6)|ovary(1)	10	Lung NSC(78;0.000991)|all_lung(78;0.00128)|Melanoma(26;0.00505)		OV - Ovarian serous cystadenocarcinoma(32;0.000268)|LUSC - Lung squamous cell carcinoma(107;0.187)|Lung(145;0.23)			ATCTGCTGGTCCAACATAGCC	0.537		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						124	125	125	NA		NA	NA	15		NA											NA				102182710		2203	4300	6503	SO:0001583	missense			ENSG00000184277	HGNC:24128	NM_078474	Approved	uc002bxi.3	NA	B2RDK9|Q9H046|Q9H651	ENST00000561373.1	37		.	.	.	.	.	.	.	.	.	.	C	26.1	4.705135	0.89018	.	.	ENSG00000184277	ENST00000347970;ENST00000333202	.	.	.	5.34	5.34	0.76211	.	0.000000	0.85682	D	0.000000	T	0.78489	0.4291	M	0.71581	2.175	0.80722	D	1	D;D	0.89917	0.999;1.0	D;D	0.79108	0.988;0.992	T	0.80238	-0.1465	9	0.72032	D	0.01	-19.4518	16.8956	0.86099	0.0:1.0:0.0:0.0	.	213;239	Q9BRN9-2;Q9BRN9	.;TM2D3_HUMAN	E	213;239	.	ENSP00000330433:G239E	G	-	2	0	TM2D3	100000233	1.000000	0.71417	0.992000	0.48379	0.860000	0.49131	7.546000	0.82137	2.660000	0.90430	0.643000	0.83706	GGA	TM2D3-006	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000415761.1	-25.969384	KEEP		-	15.700227	0.043011	8	178	---	---	---	---	1	0.9998019	15	332	0	186	10	209	0	186	2	0	0	0	0	0	0	10	209	0	186	2	TP
STX4	6810	broad.mit.edu	37	16	31050875	31050875	+	Missense_Mutation	SNP	A	A	G			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr16:31050875A>G	ENST00000394998.1	+	10	1053	c.710A>G	c.(709-711)aAt>aGt	p.N237S	STX4_ENST00000313843.3_Missense_Mutation_p.N239S|STX4_ENST00000493902.1_3'UTR	NM_001272096.1	NP_001259025.1	Q12846	STX4_HUMAN	syntaxin 4	239	Interaction with CENPF (By similarity).|t-SNARE coiled-coil homology.	NA		NA	intracellular protein transport|platelet activation|post-Golgi vesicle-mediated transport	basolateral plasma membrane|cell surface|cytosol|integral to membrane|plasma membrane enriched fraction|specific granule|vacuole	SNAP receptor activity			NS(2)|breast(1)|large_intestine(3)|lung(3)	9						GAGATGATCAATCGGATTGAG	0.567		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						115	105	108	NA		NA	NA	16		NA											NA				31050875		2197	4300	6497	SO:0001583	missense			ENSG00000103496	HGNC:11439	NM_004604	Approved	uc002eak.4	NA	Q15525|Q6FHE8	ENST00000394998.1	37		.	.	.	.	.	.	.	.	.	.	A	19.56	3.851002	0.71719	.	.	ENSG00000103496	ENST00000394998;ENST00000313843	T;T	0.23348	1.91;1.91	6.08	6.08	0.98989	t-SNARE (1);Syntaxin/epimorphin, conserved site (1);Target SNARE coiled-coil domain (3);	0.107189	0.64402	D	0.000004	T	0.32882	0.0844	M	0.69248	2.105	0.42692	D	0.993584	B;P	0.42456	0.334;0.78	B;B	0.40602	0.197;0.334	T	0.18178	-1.0345	10	0.87932	D	0	.	15.6264	0.76863	1.0:0.0:0.0:0.0	.	239;237	Q12846;A8MXY0	STX4_HUMAN;.	S	237;239	ENSP00000378447:N237S;ENSP00000317714:N239S	ENSP00000317714:N239S	N	+	2	0	STX4	30958376	1.000000	0.71417	0.998000	0.56505	0.930000	0.56654	8.526000	0.90588	2.333000	0.79357	0.533000	0.62120	AAT	STX4-003	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000438720.3	-16.306514	KEEP		+	17.120098	0.046053	7	145	---	---	---	---	1	0.9996854	12	346	0	150	8	170	0	150	2	0	0	0	0	0	0	8	170	0	150	2	TP
MYO18A	399687	broad.mit.edu	37	17	27425124	27425124	+	Splice_Site	SNP	T	T	G			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr17:27425124T>G	ENST00000527372.1	-	25	4169	c.3990_splice	c.e25+1	p.Q1330_splice	MYO18A_ENST00000354329.4_Splice_Site_p.Q1330_splice|MYO18A_ENST00000533112.1_Splice_Site_p.Q1330_splice|MYO18A_ENST00000531253.1_Splice_Site_p.Q1330_splice	NM_078471.3	NP_510880.2	Q92614	MY18A_HUMAN	myosin XVIIIA	1330		NA		NA	anti-apoptosis|DNA metabolic process	ER-Golgi intermediate compartment|myosin complex	ATP binding|DNA binding|DNA-dependent ATPase activity|identical protein binding|motor activity			NS(1)|cervix(1)|endometrium(6)|kidney(6)|lung(20)|urinary_tract(2)	36			Epithelial(11;4.97e-05)|BRCA - Breast invasive adenocarcinoma(11;0.000221)|all cancers(11;0.000234)|Colorectal(6;0.0102)|COAD - Colon adenocarcinoma(6;0.031)			TGCCCTCACCTGCAGTTCCTT	0.612		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Esophageal Squamous(182;472 2015 7001 15270 22562)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA						113	125	121	NA		NA	NA	17		NA											NA				27425124		2159	4251	6410	SO:0001630	splice_region_variant			ENSG00000196535	HGNC:31104	NM_078471	Approved	uc002hdt.1	NA	Q5H9U3|Q5W9F9|Q5W9G1|Q8IXP8	ENST00000527372.1	37	CCDS45642.1	.	.	.	.	.	.	.	.	.	.	T	20.6	4.021704	0.75275	.	.	ENSG00000196535	ENST00000354329;ENST00000359450;ENST00000533112;ENST00000531253;ENST00000527372;ENST00000529799;ENST00000540575;ENST00000458428	T;D;T;T	0.88818	-1.16;-2.43;-1.16;-1.16	5.36	5.36	0.76844	Myosin tail (1);	0.000000	0.85682	D	0.000000	D	0.92496	0.7617	M	0.81802	2.56	0.51012	D	0.999902	P;P;P;P;D	0.53312	0.813;0.937;0.937;0.937;0.959	P;P;P;P;P	0.53006	0.715;0.626;0.504;0.504;0.681	D	0.93169	0.6564	10	0.56958	D	0.05	.	15.6464	0.77055	0.0:0.0:0.0:1.0	.	999;942;1330;1330;1330	Q92614-2;F8W6Y3;Q92614-3;Q92614-4;Q92614	.;.;.;.;MY18A_HUMAN	P	1330;1330;1330;1330;1330;226;226;942	ENSP00000346291:Q1330P;ENSP00000435932:Q1330P;ENSP00000434228:Q1330P;ENSP00000437073:Q1330P	ENSP00000346291:Q1330P	Q	-	2	0	MYO18A	24449250	1.000000	0.71417	1.000000	0.80357	0.380000	0.30137	7.511000	0.81718	2.157000	0.67596	0.533000	0.62120	CAG	MYO18A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000389396.1	-43.851197	KEEP	Missense_Mutation	-	15.735914	0.03861	10	249	---	---	---	---	1	0.8357333	2	87	0	213	10	264	0	213	2	0	0	0	0	0	0	10	264	0	213	2	TP
TRIP10	9322	broad.mit.edu	37	19	6741105	6741105	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr19:6741105G>A	ENST00000313244.9	+	2	144	c.109G>A	c.(109-111)Gaa>Aaa	p.E37K	TRIP10_ENST00000313285.8_Missense_Mutation_p.E37K|TRIP10_ENST00000596758.1_Missense_Mutation_p.E37K|TRIP10_ENST00000596543.1_3'UTR|TRIP10_ENST00000600428.1_5'UTR			Q15642	CIP4_HUMAN	thyroid hormone receptor interactor 10	37	FCH.|Induction of membrane tubulation.|Required for podosome formation and interaction with AKAP9 and microtubules.|Required for translocation to the plasma membrane in response to insulin (By similarity).	NA		NA	actin cytoskeleton organization|cell communication|endocytosis|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction	cell cortex|cell projection|cytoskeleton|cytosol|Golgi apparatus|lysosome|perinuclear region of cytoplasm|phagocytic cup	GTPase activator activity|identical protein binding|lipid binding			NS(1)|breast(1)|endometrium(1)|large_intestine(1)|liver(2)|lung(7)|ovary(1)|prostate(1)|urinary_tract(1)	16						AGAACGCACCGAAGTGGAACA	0.627		NA				NA							NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA			NA	NA		NA				0			NA	NA	NA	NA	NA						75	66	69	NA		NA	NA	19		NA											NA				6741105		2203	4300	6503	SO:0001583	missense			ENSG00000125733	HGNC:12304		Approved	uc002mfr.3	NA	B2R8A6|B7WP22|D6W645|O15184|Q53G22|Q5TZN1|Q6FI24|Q8NFL1|Q8TCY1|Q8TDX3|Q96RJ1	ENST00000313244.9	37		.	.	.	.	.	.	.	.	.	.	G	24.5	4.539337	0.85917	.	.	ENSG00000125733	ENST00000313285;ENST00000313244;ENST00000420690	T;T	0.46063	0.88;2.28	4.11	4.11	0.48088	Fps/Fes/Fer/CIP4 homology (3);	0.063503	0.64402	D	0.000008	T	0.62865	0.2463	M	0.76574	2.34	0.58432	D	0.999999	D;D;D	0.89917	1.0;0.998;0.998	D;D;P	0.72625	0.978;0.971;0.744	T	0.68138	-0.5488	10	0.66056	D	0.02	-24.7607	13.836	0.63410	0.0:0.0:1.0:0.0	.	37;37;37	G5E9U1;Q15642;Q15642-2	.;CIP4_HUMAN;.	K	37	ENSP00000320493:E37K;ENSP00000320117:E37K	ENSP00000320117:E37K	E	+	1	0	TRIP10	6692105	1.000000	0.71417	0.921000	0.36526	0.929000	0.56500	9.078000	0.94023	1.834000	0.53371	0.462000	0.41574	GAA	TRIP10-003	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000317129.2	-17.087265	KEEP		+	6.857036	0.038462	4	100	---	---	---	---	1	0.9822927	9	220	0	98	4	111	0	98	2	0	0	0	0	0	0	4	111	0	98	2	TP
GNAS	2778	broad.mit.edu	37	20	57485115	57485115	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GY-Tumor-SM-2HRMH	THCA-TCGA-EL-A3GY-Normal-SM-2HRMM	g.chr20:57485115C>A	ENST00000371100.4	+	11	3430	c.2878C>A	c.(2878-2880)Cgc>Agc	p.R960S	GNAS_ENST00000371075.3_3'UTR|GNAS_ENST00000464624.2_3'UTR|GNAS_ENST00000306090.10_Missense_Mutation_p.R303S|GNAS_ENST00000371085.3_Missense_Mutation_p.R317S|GNAS_ENST00000371095.3_Missense_Mutation_p.R303S|GNAS_ENST00000354359.7_Missense_Mutation_p.R318S|GNAS_ENST00000371102.4_Missense_Mutation_p.R946S|GNAS_ENST00000313949.7_3'UTR|GNAS_ENST00000265620.7_Missense_Mutation_p.R302S	NM_001077490.1|NM_080425.2	NP_001070958.1|NP_536350.2	P63092	GNAS2_HUMAN	GNAS complex locus	317		NA		NA	activation of adenylate cyclase activity|cellular response to glucagon stimulus|energy reserve metabolic process|G-protein coupled receptor protein signaling pathway|intracellular transport|platelet activation|regulation of insulin secretion|sensory perception of smell|transmembrane transport|water transport	heterotrimeric G-protein complex|intrinsic to membrane|trans-Golgi network membrane	adenylate cyclase activity|GTP binding|GTPase activity|guanyl-nucleotide exchange factor activity|identical protein binding|signal transducer activity			adrenal_gland(12)|autonomic_ganglia(1)|biliary_tract(5)|central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(4)|kidney(7)|large_intestine(37)|liver(9)|lung(9)|ovary(16)|pancreas(56)|parathyroid(5)|pituitary(228)|prostate(2)|small_intestine(1)|stomach(1)|testis(2)|thyroid(35)|upper_aerodigestive_tract(3)|urinary_tract(1)	441	all_lung(29;0.0104)		BRCA - Breast invasive adenocarcinoma(13;2.19e-08)|Colorectal(105;0.109)			AGAATTTGCTCGCTACACTAC	0.493		NA	Mis		pituitary adenoma	NA	"""McCune-Albright syndrome; pseudohypoparathyroidism, type IA"""			TSP Lung(22;0.16)			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(117;935 1597 6045 8307 46442)	NA	Dom	yes	NA	20	20q13.2	2778	"""guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1"""	yes	E	0			NA	NA	NA	NA	NA						178	178	178	NA		NA	NA	20		NA											NA				57485115		2203	4300	6503	SO:0001583	missense			ENSG00000087460	HGNC:4392	NM_000516	Approved	uc002xzw.3	NA	E1P5G5|P04895|Q12927|Q14433|Q32P26|Q5JWD2|Q5JWD4|Q5JWD5|Q6NR75|Q6NXS0|Q8TBC0|Q96H70	ENST00000371100.4	37	CCDS46622.1	.	.	.	.	.	.	.	.	.	.	C	14.20	2.465132	0.43839	.	.	ENSG00000087460	ENST00000371100;ENST00000371102;ENST00000371095;ENST00000371085;ENST00000354359;ENST00000265620;ENST00000306090;ENST00000371082	D;D;D;D;D;D;D	0.81739	-1.53;-1.53;-1.53;-1.53;-1.53;-1.53;-1.53	5.01	5.01	0.66863	.	0.238619	0.25546	N	0.029940	D	0.83903	0.5355	M	0.66506	2.035	0.80722	D	1	B;B;B;P	0.38978	0.005;0.005;0.002;0.652	B;B;B;P	0.44732	0.015;0.025;0.014;0.459	D	0.85594	0.1248	10	0.62326	D	0.03	.	18.663	0.91478	0.0:1.0:0.0:0.0	.	317;318;302;960	P63092;A6NI00;P63092-3;Q5JWF2	GNAS2_HUMAN;.;.;GNAS1_HUMAN	S	960;946;303;317;318;302;303;83	ENSP00000360141:R960S;ENSP00000360143:R946S;ENSP00000360136:R303S;ENSP00000360126:R317S;ENSP00000346328:R318S;ENSP00000265620:R302S;ENSP00000304472:R303S	ENSP00000265620:R302S	R	+	1	0	GNAS	56918510	1.000000	0.71417	1.000000	0.80357	0.985000	0.73830	7.345000	0.79337	2.468000	0.83385	0.467000	0.42956	CGC	GNAS-001	PUTATIVE	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000080417.3	-68.552652	KEEP		+	6.332634	0.014337	4	275	---	---	---	---	1	1	4	8002	0	301	6	322	0	301	2	0	0	0	0	0	0	6	322	0	301	2	TP
